BACKGROUND: This study has addressed concerns about possible effects of feeding human infants soy formula milk (SFM). METHODS: This is a feeding study in marmosets, using a mainly co-twin design. From 4-5 until 35-45 days of age, co-twin males were fed by hand with either standard (cow) formula milk (SMA ⍧ controls) or with SFM for~8 h each day (2 h at weekends) and intake related to bodyweight. Blood samples were collected at 18-20 and at 35-45 days of age in 13 sets of co-twins plus two non-twin males per group and, at the later age, seven sets of co-twins were killed and the testes and pituitary gland fixed for cell counts. RESULTS: Weight gain and formula intake were similar in both feeding groups. SMA-fed males had mean testosterone levels of 2.8-3.1 ng/ml, typical of the 'neonatal testosterone rise', whereas SFM-fed males exhibited consistently lower mean levels (1.2-2.6 ng/ml); paired comparison in SMA-and SFM-fed co-twins at day 35-45 revealed 53-70% lower levels in 11 of 13 co-twins fed with SFM (P ⍧ 0.004). Further evidence for suppression of testosterone levels in SFM-fed males came from comparison of the frequency of low testosterone levels (<0.5 ng/ml). In historical controls aged 35-45 days, two out of 22 values were <0.5 ng/ml, a similar frequency as found in control SMA-fed males (one out of 15 values <0.5 ng/ml). In contrast, 12 out of 15 values for SFM-fed males were <0.5 ng/ml (P < 0.001). There was no consistent relationship between SFM intake/g and testosterone levels. Paradoxically, the mean number of Leydig cells per testis was increased by 74% (P < 0.001) in co-twins fed SFM, when compared with their SMA-fed brothers, whereas no significant changes were found in numbers of Sertoli and germ cells. Because of the lack of gonadotrophin assays, the number of immunopositive LHβ and FSHβ cells in the pituitary gland, and their ratio, were determined but no consistent difference was found between SMA-and SFM-fed twins. CONCLUSIONS: Based on the average isoflavone content of the SFM brand used, intake of isoflavones was estimated at 1.6-3.5 mg/kg/day in the SFM-fed marmosets which is 40-87% of that reported in 4 month human infants fed on a 100% SFM diet. It is therefore considered likely that similar, or larger, effects to those shown here in marmosets may occur in human male infants fed with SFM. Whether the changes described result in longer-term effects is under investigation.
Introduction
Within the last half-century, there have been major changes in Western countries in the type of feeding offered to human infants prior to weaning. This has involved predominantly a switch from breastfeeding to formula milk feeding based on cow's milk but, more recently, powdered milk formula derived from soybean extracts has been introduced and has been used for human infant feeding in various countries. The use of soy formula milk (SFM) was originally advocated or prescribed for infants exhibiting features of intolerance to cow's milk formula (Polack et al., 1999) . However, based on current estimates of the prevalence of feeding SFM to infants (2-3% in the UK and Australia, 20-25% in the USA and Canada)
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(UK Department of Health, 1996; Australian College of Paediatrics, 1998; American Academy of Pediatrics Committee on Nutrition, 1998; Canadian Pediatric Society, Dieticians of Canada, Health Canada, 1998) , it is apparent that this is no longer the case and that SFM is often the breastmilk substitute of choice for many mothers and is frequently used within the first months of life (Polack et al., 1999) . Although careful studies have demonstrated comparable growth rates of infants fed on either SFM or a more conventional cow's milk formula (Jung and Carr, 1977; Kohler et al., 1984; Mimouni et al., 1993; Lasekan et al., 1999) , concerns have been expressed as to whether or not the high isoflavenoid phytoestrogen content of SFM might exert adverse effects on the developing infant (Irvine et al., 1995 (Irvine et al., , 1998a Setchell et al., 1997 Setchell et al., , 1998 ).
These concerns have arisen because of a number of factors. First, evidence that isoflavenoid phytoestrogens, such as genistein and daidzein, or other phytoestrogens, can exert a range of effects in animals such as birds, rodents, cheetahs and sheep (Irvine et al., 1995; Whitten et al., 1995; Whitten and Naftolin, 1999) . These effects can apply to both sexes and, in highly susceptible species such as the sheep, can include irreversible infertility (in the female) (Whitten and Naftolin, 1999) ; in rodents, neonatal exposure of female pups directly to phytoestrogens or indirectly via their mother's milk can cause ovulatory cycle problems later in life (Whitten et al., 1995; Whitten and Naftolin, 1999) . Second, the growing evidence from laboratory animal studies that even brief neonatal exposure to (potent) estrogens can induce a spectrum of changes to the testis (Sertoli and Leydig cells) and reproductive tract and their function (Toppari et al., 1996; Atanassova et al., 1999; Williams et al., 2001) . Third, the finding that~4 month human infants fed on a 100% SFM diet have blood levels of isoflavenoids that are ജ5-fold higher than those of adult humans eating a soy rich diet (Setchell et al., 1997 (Setchell et al., , 1998 Irvine et al., 1998a,b) . The latter studies concluded that such levels are almost certain to exert (unknown) biological effects, though opinion is divided as to whether these are likely to be adverse (Irvine et al., 1998a,b) or beneficial (Setchell et al., 1997) .
In contrast to the above concerns, there is also interest in the potential beneficial effects of consuming phytoestrogens/ soy. This is because Oriental countries in which the traditional diet is rich in soy products, such as Japan and China, have a low incidence of breast cancer, invasive prostate cancer and cardiovascular disease, and it has been argued, though not proven, that this stems from soy and/or phytoestrogen consumption (Adlercreutz, 1990; Adlercreutz and Mazur, 1997) . If soy consumption does have beneficial health effects it is unclear whether these result from lifetime exposure or might, for example, result from exposure during a critical period during development. Based on this possibility, the feeding of SFM to infants could have potential lifelong health beneficial effects (Setchell et al., 1997) , though it is emphasized that feeding of soy products, including SFM, to infants in the first 4-6 months has not been traditional in Oriental countries (Guy and Yeh, 1938) .
There are no reports in the literature on human infants fed with SFM that help to distinguish between the two opposing possibilities given above, though a recent (retrospective) cohort study, based on telephone interviews, reported no overt reproductive problems in young adults fed as infants with SFM (Strom et al., 2001) . As no major adverse effects of feeding SFM have come to light since its widespread introduction more than 30 years ago, it has been argued that adverse effects are unlikely (Klein, 1998) . Though numerous studies in infant rodents have examined the effects of exposure to phytoestrogens during the neonatal period (Whitten and Naftolin, 1999) , it is unknown whether these are relevant to human infants for two important reasons. First, the route and mode of administration of phytoestrogens are generally not comparable. In rodents, the compounds have usually been injected (once daily) rather than being consumed orally by the pups, 1693 and though some studies have administered soy, SFM or phytoestrogens to the lactating mother, this is not directly comparable with its consumption by the pups themselves (Setchell et al., 1997; Irvine et al., 1998a) . Second, neonatal rodents are relatively undeveloped when compared with neonatal human infants and may therefore be more vulnerable to effects of hormonally active compounds. With regard to male human infants there is a third and potentially important difference from rodents, namely the occurrence of a prolonged 'neonatal testosterone rise' when testosterone levels increase to low adult levels during the first 4-6 months of life, associated with activation of gonadotrophin secretion (Winters et al., 1975; Forest, 1990; Mann and Fraser, 1996; Andersson et al., 1998) , Sertoli cell proliferation (Cortes et al., 1987; Sharpe, 1999) and a steep rise in the secretion of inhibin B by the latter cells (Andersson et al., 1998) . In contrast, if a neonatal testosterone rise occurs in rodents it is restricted to a matter of hours around the day of birth. The role of the neonatal testosterone rise in the human male remains unclear, though effects on the immune system (Mann and Fraser, 1996) , on sexually dimorphic brain development (Mann and Fraser, 1996) , the testis and reproductive tract (Mann and Fraser, 1996; Sharpe et al., 2000; McKinnell et al., 2001) , and genitalia (Wallen et al., 1995; Mann and Fraser, 1996; Brown et al., 1999) are distinct possibilities, based on studies in non-human primates which also exhibit a neonatal testosterone rise (Wallen et al., 1995; Mann and Fraser, 1996; Brown et al., 1999; McKinnell et al., 2001) .
Because of the widespread prevalence of feeding human infants with SFM, it is clearly important to establish whether this is likely to have any biological consequences, in particular to identify or rule out the possibility of adverse effects (Irvine et al., 1998a) . To address this issue, we have undertaken a feeding study in a non-human primate, the marmoset, and report in this paper the effects observed during and at the end of the feeding period which encompassed the period of the neonatal testosterone rise.
Materials and methods
Animals and treatments
Animals were captive-bred common marmoset monkeys (Callithrix jacchus), maintained in a colony that has been self-sustaining since 1973. For the present studies, a total of 30 newborn male marmosets were used, of which 26 were 13 pairs of co-twins. Marmosets show considerable between-animal variability that would normally necessitate the use of larger numbers of animals, based on power calculations. To minimize between-animal variability, the present study used predominantly co-twins (one SMA-fed, one SFM-fed), which tend to be highly comparable, and this enabled pair-wise evaluation of data and thus minimized the use of animals. Commencing at 4-5 days of age, infant marmosets were treated as follows. During the daytime (~8 h on weekdays,~2 h at weekends), infant animals were separated from their mothers and left with their fathers in the family cage, though, by using a wire mesh divider, they remained within sight of their mothers. As our marmosets are maintained in family groups and it is normally the father or older siblings who look after infant marmosets (apart from feeding), this daytime separation caused no obvious distress or problems for either mothers or infants.
During the period when the mother was absent from the family cage, the infant animals were removed at set intervals and hand-fed with either standard (cow's milk-based) formula milk (SMA Gold; SMA Nutrition, Taplow, Berkshire, UK) or with SFM (Wysoy; SMA Nutrition) from day 4/5 until day 35-45; both formulae milks were purchased from a supermarket. The formula powders were added to tapwater and heated and diluted as per the manufacturer's instructions. The suspension was taken up into a 1 ml syringe with a soft silicon rubber tube fitted to the end and offered to the infant marmoset, which was allowed to drink as much of the milk as it wanted from the tube. The syringe was refilled as appropriate and offered to the marmoset until it decided to stop drinking. The amount of formula taken was recorded and animals were weighed each day prior to feeding. Infants were fed three or four times (weekdays) or once or twice daily (weekends) and habituated well to the routine. After the last formula feed of the day, the infant's mother was returned to the family cage and she was allowed to breastfeed her infants until the following morning. Both SMA-fed (controls) and SFM-fed animals showed normal rates of weight gain during the study period. The isoflavone content of the SFM used in the present studies was not measured, but based on analyses of various soy-based infant formulae bought in the UK, levels in the range 18-41 mg aglycone/l would be predicted and mean levels of 25.5 mg aglycone/l were reported for the particular brand of SFM that we used (Ministry of Agriculture, Food and Fisheries, 1998; Irvine et al., 1998a; Knight et al., 1998; Setchell et al., 1998) ; isoflavones were not detected in any of the brands of cow's formula milk that were analysed (Ministry of Agriculture, Food and Fisheries, 1998) . In all other respects, SFM has been constituted to provide comparable nutritional/calorific intake with cow's milk-based infant formulae.
Approximately half-way through the study (day 18-20, 14:30-16:30) , a blood sample (~0.2 ml) was obtained from the femoral vein of each infant using a 1 ml syringe fitted with a 27G needle. It was not necessary to sedate the animals for this procedure as it caused no obvious discomfort. On day 35-45, seven sets of co-twins were killed via the i.p. injection of an overdose of sodium pentobarbitone (Euthatal; Rhone Merieux Ltd, Harlow, Essex, UK). Immediately after death (10:00-11:30) a terminal blood sample was obtained by cardiac puncture. Each blood sample was collected into a heparinized syringe and the plasma then separated by centrifugation and stored at -20°C until used for assay. The remaining 16 animals (eight SMAfed, eight SFM-fed), including six sets of co-twins, had a blood sample collected at day 35-45 (14:30-16:30) but were then returned to their cages and treatment discontinued. These animals are currently growing to adulthood when the possibility of any long-term effects of the SFM exposure will be evaluated.
These studies were approved by the local ethical committee for studies in primates and were performed according to the Animal Scientific Procedures (UK) Act (1986) under Project Licence approval by the UK Home Office.
Tissue collection and processing
Testes with epididymides attached, as well as the pituitary gland, were dissected free of connective tissue and immersion-fixed for either 5.5 h (left testis, pituitary gland) or 24 h (right testis) in Bouin's fluid, after which each testis was dissected away from the epididymis and weighed. The left testis and pituitary gland were then processed for 17.5 h in an automated Leica TP-1050 processor and embedded in paraffin wax. Sections of 5 µm thickness were cut and floated onto slides coated with 2% 3-aminopropyltriethoxy-silane (Sigma, Poole, Dorset) and dried at 50°C overnight before being used for morphological evaluation and for cell quantification studies as described below. After fixation, the right testis was sampled in a random 1694 systematic manner, i.e. of four transverse slices, either slices, 1 and 3 or slices 2 and 4 were sampled. These were processed through graded ethanols before infiltration with JB4 resin (TAAB, Aldermaston, Berkshire, UK) and used subsequently for enumeration of Sertoli and germ cells using the optical disector method (see below).
Determination of Sertoli and germ cell numbers per testis
After polymerization of the JB4 resin, 20 µm sections were cut on a Reichart 2050 microtome using a Diatome Histoknife, mounted onto glass slides and stained with Harris' haematoxylin. Sertoli and germ cells were then counted using the optical disector method (Wreford, 1995) as reported previously by us for the marmoset (Sharpe et al., 2000) .
Determination of Leydig cell number and immunoexpression of 17α-hydroxylase/C 17-20 lyase
Leydig cell volume per testis was determined using paraffin sections of testis that had been immunostained for 3β-hydroxysteroid dehydrogenase (3β-HSD) as described previously (Sharpe et al., 2000) . The method used the Area Fraction Probe in the Stereologer software programme (Systems Planning and Analysis Inc., Alexandria, VA, USA) and utilized an Olympus BHS microscope fitted with an automatic stage (Applied Scientific Instrumentation Inc., Eugene, OR, USA). The area fraction probe places a grid in the frame and the Object Area fraction is determined by clicking each 'ϫ' that touches the object of interest (in this case, the cytoplasm or nucleus of 3β-HSD positive cells). The number of frames per slide counted was 5-13 and was determined by the program after taking into account the spacing between points, objects counted per frame and the size of the section. Frames for evaluation were selected automatically. A coefficient of error (CE) was calculated at intervals in the counting procedure and, if this exceeded the maximum acceptable value (0.15), then different settings recommended by the program were utilized in order to obtain the optimum CE. Once completed, Stereologer automatically displays the results including area fraction and CE. The values for area fraction were then converted to absolute volumes per testis by reference to testis volume (ϭ weight). Average nuclear diameter was then determined by measuring the diameter of 100 random nuclei of 3β-HSD positive cells for each animal and then converting Leydig cell nuclear volume per testis to Leydig cell number per testis (Wreford, 1995) .
Immunoexpression of P450 17α-hydroxylase/C 17-20 lyase utilized an antiserum provided kindly by Professor Ian Mason (Edinburgh). The methods used have been detailed previously (Majdic et al., 1996) , and were broadly similar to those described above for 3β-HSD.
Immunostained sections were examined and photographed using a Provis microscope (Olympus Optical, London, UK) fitted with a digital camera (DCS330; Eastman Kodak, Rochester, NY, USA). Captured images were transferred to a computer (G4; Apple Computer Inc., Cupertino, CA, USA) and compiled using Photoshop 5.0 (Adobe Systems Inc., Mountain View, CA, USA) before being printed using an Epson Stylus 870 colour printer (Seiko Epson Corp., Nagano, Japan).
Plasma levels of testosterone
Levels of testosterone in plasma were measured using an enzymelinked immunosorbent assay (ELISA) adapted from an earlier radioimmunoassay method (Corker and Davidson, 1981) . Plasma, to which was added trace amounts of [ 3 H]testosterone (Amersham International, Little Chalfont, Bucks, UK), was extracted twice with 10 vols hexane:ether (4:1, v/v) and the organic phase dried down under N 2 at 55°C. The efficiency of extraction averaged 75%. The second antibody was immobilized to an ELISA plate by addition of 100 µl acid-purified donkey anti-goat/sheep IgG (250-350 mg/ml) diluted in 0.1 mol/l sodium carbonate buffer, pH 9.6. The plate was sealed and incubated overnight at 4°C. The wells were then washed twice with 0.1% Tween-20 and incubated for 10 min at room temperature with 0.2 ml of the same solution to block non-specific binding sites. Samples in duplicate (50 µl) were assayed after dilution in 0.1 mol/l PBS, pH 7.4 containing 0.1% gelatin (Sigma) and incubated overnight at 4°C with 50 µl sheep anti-testosterone-3-cmo-bovine serum albumin (BSA) diluted 1:100 000 plus 50 µl testosterone-3-cmo labelled with 1:20 000 horse-radish peroxidase (Amdex; Amersham Pharmacia Biotech, St Albans, Herts, UK). The plate was then washed several times with 0.1% Tween-20 before addition of 0.2 ml substrate (5 mmol/l O-phenylenediamine; Sigma) and 0.03% hydrogen peroxide diluted in 0.1 mol/l citrate/phosphate, pH 5.0 to each well. The plate was then incubated in the dark for 10-30 min until the colour reaction was optimal. The reaction was stopped by addition of 50 µl 2 mol/l sulphuric acid to each well and the optical density then read at 492 nm in a plate reader. The limit of detection was 12 pg/ml and inter-and intra-assay coefficients of variation were Ͻ15%. Samples from first and second bleeds from each set of twins were always extracted and assayed at the same time.
Enumeration of LHβ-and FSHβ-immunopositive cells in the pituitary gland
Paraffin-embedded pituitary glands were sectioned transversely until approximately the midline and consecutive sections from the midline region were then immunostained for LHβ and FSHβ using specific antibodies as reported previously (Brown et al., 2001) . FSHβ was detected using a polyclonal rabbit antibody raised against human FSHβ (M94, gift from Dr S.Lynch, Birmingham, UK) and LHβ using a monoclonal mouse antibody raised against bovine LHβ (518B7, gift from Dr J.F.Roser, University of California-Davis, USA).
Unless otherwise stated, all incubations were performed at room temperature. Sections were cut at 5 µm and floated onto slides coated with either 2% 3-aminopropyltriethoxy-silane (Sigma) or poly-lysine (BDH Chemicals, Poole, Dorset, UK) and dried overnight at 50°C. The slides were dewaxed, rehydrated and endogenous peroxidase was blocked using 3% (v/v) hydrogen peroxide in methanol. After washing in water, the sections were washed twice (5 min each) in Tris-buffered saline (0.05 mol/l TBS, pH 7.4 and 0.85% NaCl). For FSHβ, slides were then blocked for 30 min with normal swine serum (NSS; Diagnostics Scotland, Carluke, UK) diluted 1:5 in TBS containing 5% BSA; for LHβ, slides were blocked with normal rabbit serum (NRS) diluted 1:5 in TBS with 5% BSA. The primary antibodies were diluted in the appropriate blocking solution (FSHβ 1:1000; LHβ 1:5000) and 100 µl was added to each slide before incubation at 4°C overnight in a light-proof humidity chamber. The slides were then washed in TBS (2ϫ5 min) before incubation for 30 min with a biotinylated second antibody, namely swine anti-rabbit (Dako, Ely, UK) for FSHβ or rabbit anti-mouse (Dako) for LHβ, diluted 1:500 in the appropriate blocking serum. After two washes in TBS (2ϫ5 min), avidin-biotin conjugated horse-radish peroxidase (ABC-HRP; Dako) was applied for 30 min. After two final washes (2ϫ5 min) in TBS a solution of diaminobenzidine (DAB) was applied (liquid DAB; Dako). The slides were developed until the colour reached the required intensity in the control sections, and the reaction was then stopped by immersing the slides in distilled water. The slides were counterstained with haematoxylin before being dehydrated by immersion in a graded series of ethanols and then being cleared in xylene. A coverslip was fixed over the sections using Pertex mounting medium (Cell Path, Hemel Hempstead, UK).
Immunolocalization studies for FSHβ and LHβ were repeated on two separate occasions for each of four sets of co-twin marmosets and showed good agreement between runs. Sections from control and 1695 treated animals were run in parallel at all times. Immunostained sections were examined on a Zeiss Axioskop light microscope using a ϫ40 objective. The number of immunopositive cells was determined by placing a 21 mm diameter graticule over a randomly chosen area of the anterior pituitary. Within that graticule, the number of immunopositive (nucleated) cells (brown) was counted and the total number of non-immunopositive cells (blue) was also counted and the percentage immunopositive cells then calculated. This was done for four randomly chosen areas on each slide and repeated once. Final data for each animal were then computed as the average of the two runs.
Statistics
As predominantly co-twins were used for this study, paired t-test comparison of bodyweight, testis weight and cell number/volume data for SMA-fed (controls) and SFM-fed animals was utilized for all such comparisons. In most instances, data were log-transformed prior to analysis because of the considerable variation between sets of twins and because of heterogeneity of variance (especially for testosterone levels). Frequency of testosterone levels in a particular range utilized Fisher's exact test. Correlation analysis between formula intake and plasma testosterone levels utilized simple linear regression.
Results
Bodyweight, testis weight and formula intake
Bodyweights in SMA-fed and SFM-fed infants were comparable at the start and end of the period of treatment and bodyweight increment during this period was also comparable (Table I ) and was within normal limits for our colony of marmosets. Values were similar for co-twins (n ϭ 13) and for the total study set that included two sets of singleton infants per treatment group (Table I ). All animals appeared healthy and there were no unexpected problems in running the study. There was considerable variation between twins in the level of formula intake and in most cases this variation applied equally to both co-twins. In most infants (SMA 11/15, SFM 13/15), formula intake per gram bodyweight was higher in the second half of the study (i.e. after the first bleed) than in the first half (i.e. prior to the first bleed) and comparison of formula intake in the 7 days immediately preceding the day of first and second blood sampling revealed a significantly higher intake prior to the second bleed, which was especially marked for SFM-fed infants (Table I) . Typical formula intake patterns for two sets of co-twins are shown in Figure 1 . Three males fed with SFM were slightly more reticent in taking the feed at the start of the study whereas others clearly enjoyed taking the feed from the start. These and the between-twin differences account for the considerable variation in overall intake of formula per day between animals (Figure 2 , top panel). Testis weight in the seven sets of co-twins that were killed at 35-45 days were not significantly different for SMAand SFM-fed animals (Table I and Figure 2 ).
Plasma testosterone levels and the relationship to soy formula intake
At both day 18-20 and day 35-45, plasma levels of testosterone in control marmosets fed with SMA exhibited typical mean levels for neonatal marmosets of~2.8-3.1 ng/ml but with a wide range (high SD), reflecting the episodic nature of testosterone secretion (Tables I and II, Figure 2 ). Mean testosterone levels in animals fed SFM were 30% lower at day 18-20 and 55% lower at day 35-45 when compared with the SMA group (Table I) . Paired comparison of (log-transformed) testosterone levels in co-twins at day 35-45 revealed a statistically significant (P ϭ 0.004) difference (Figure 2 ), but similar comparison at day 18-20 was not significant (P ϭ 0.2). This age difference in effect could not be explained by difference in time of sample collection (day 18-20 all collected after noon; day 35-45, seven twin samples collected in the morning and 8 samples after noon), but might be related to the 49% average increase in SFM intake per gram bodyweight prior to the second blood sample, when compared with intake prior to the first blood sample (Table I) . However, using data for both timepoints, no consistent or significant relationship between SFM intake/g/day and testosterone levels was found (not shown). Although testosterone levels varied considerably between males, as shown in Figure 2 , it was apparent that males fed with SFM had more low values (Ͻ0.5 ng/ml) than did SMA-fed males ( Figure 2 , Table II ). Testosterone levels Ͻ0.5 ng/ml did occur sporadically because of episodicity, but they did not occur with such high frequency as in the SFM-fed group in which 80% of testosterone values were Ͻ0.5 ng/ml at day 35-45 (Table II) . In contrast, in both the SMA-fed animals and in an historical cohort of 22 measurements made in the same age range in control animals, only 8 and 7% respectively of testosterone values were Ͻ0.5 ng/ml. The frequency of testosterone values Ͻ0.5 ng/ml in SFM-fed males was significantly different (P Ͻ 0.001) from that in both SMA-fed males and the historical cohort, whereas the latter two groups were comparable (Table II) . The historical cohort also showed mean Ϯ SD levels of testosterone that were comparable with the SMA-fed animals at day 35-45 (Table II) . A similar comparison of testosterone values Ͻ0.5 ng/ml in SMA-and SFM-fed animals at day 18-20 did not show any significant difference (data not shown).
Testicular cell counts and immunoexpression of 17α-hydroxylase/C 17-20 lyase
Sertoli cell number per testis did not show any consistent change between SMA-and SFM-fed co-twins, nor did germ cell numbers per testis, although SFM-fed twins showed lower values than their SMA-fed brothers in six out of seven cases (Figure 3 ). The most marked and consistent change (P ϭ 0.006) in testicular cell composition in SFM-fed co-twins, when compared with SMA-fed co-twins at day 35-45, was in Leydig (3β-HSD immunopositive) cell numbers, which were increased by an average of 74% (Figures 3 and 4) . As there are several examples in the literature of reduced testosterone levels being associated with low expression of 17α-hydroxylase/C 17-20 lyase (Cigorraga et al., 1980; Majdic et al., 1996) , immunoexpression of this enzyme was assessed in four sets of twins. However, no evidence for a consistent reduction in intensity of immunoexpression of this enzyme was detected (data not shown).
Number of LHβ and FSHβ immunopositive cells in the pituitary gland
There are currently no workable assays for measuring blood gonadotrophins in the marmoset. To obtain some insight as to whether feeding with SFM might have affected the gonadotrophin axes, the numbers of LHβ-and FSHβ-immunopositive Figure 1 . Feeding records of two sets of marmoset co-twins fed with either standard (cow) formula milk (SMA) or soy formula milk (SFM). The upper feeding record is typical of the majority of animals in the present study in that it shows a clearly higher intake of formula in both twins in the second half of the study period (dashed line shows the overall mean intake/g bodyweight). In contrast, the lower feeding record is from twins in which there was little change in formula intake during the study, a pattern shown in only a minority of animals. The times of blood sampling (arrows) and the actual level of testosterone measured are also indicated. Small hatched bars indicate weekends.
cells in the pituitary gland were determined in all sets of cotwins ( Figure 5 ). No statistically significant differences in numbers of LHβ-or FSHβ-immunopositive cells, or their ratio, was observed though mean values for each parameter were lower for SFM-fed twins ( Figure 5 ).
Discussion
The purpose of this study was to examine whether the feeding of SFM to infant marmosets, using similar ad-libitum feeding (controlled by the infants) as occurs in human infants fed with SFM, resulted in any detectable effects on the developing testis or on hormone levels. Our choice of the marmoset for these studies was based on its comparability with the human in terms of exhibiting a period of neonatal hormone activity ('testosterone surge') (Dixson, 1986; Lunn et al., 1994; Mann and Fraser, 1996; McKinnell et al., 2001) and Sertoli cell proliferation (Sharpe et al., 2000) , and the high prevalence (80%) of dizygotic twins which enabled us to use a co-twin comparison that minimized the number of animals required to be used. Feeding with SFM resulted in a significant suppression of the 'testosterone surge', at least during the second half of the feeding study. The reason why testosterone levels were suppressed at days 35-40 but not at days 18-20 in SFM-fed males is not clear but may be related to longer duration of exposure to SFM or to the 49% higher intake of SFM prior to the second, compared with prior to the first, blood sample. Paradoxically, there was a commensurate increase in Leydig cell numbers per testis when SFM-fed twins were compared with their SMA (standard formula)-fed co-twin brothers, whereas Sertoli and germ cell numbers and overall testis weight were not significantly different in both feeding groups. These findings raise the likelihood of similar, and perhaps more marked, effects in human infant boys fed with SFM, though it is unclear whether such effects would have any major or untoward consequences. There are two major considerations that arise from this study. First, to what extent does the present study reproduce the feeding pattern and level of intake of SFM and its constituent isoflavenoid phytoestrogens in human infants fed with SFM? Though the discussions below are focused on intake of phytoestrogen isoflavones, it is recognized that other constituents of the SFM may be responsible for the biological effects in our studies. Second, what are the likely consequences of altered neonatal testosterone levels and Leydig cell numbers following feeding with SFM?
Human infants aged 4 months and fed solely with SFM ingest an average of~4 mg/kg/day of isoflavones (Setchell et al., 1997) and are likely to have up to six feeds per day depending on age. Due to manpower and animal welfare Figure 2 . Plasma levels of testosterone at the end of the feeding period (35-40 days of age) (middle panel) in co-twin marmosets, fed with either standard (cow) formula milk (SMA) or soy formula milk (SFM), in relation to the mean intake of SMA or SFM/g bodyweight during the study period (top panel) and testis weight (lower panel). Each bar in the main panels represents one co-twin whilst overall mean levels for each treatment group are shown to the right. Note that results are plotted in order of descending intake of SFM/g bodyweight by the SFM-fed co-twin (top). Note also that testis weights are shown only for the seven sets of co-twins killed at 35-40 days of age, and cell count data for these organs are illustrated in Figure 3 . P-Values shown to the right are based on co-twin comparison using the paired t-test after logarithmic transformation of the data. NS ϭ not significant. considerations, we were unable to consider around the clock feeding in our marmoset study, with the result that 8 h of hand-feeding with SMA or SFM (only 2 h at weekends) and three or four feeds per day (one or two at weekends) was the closest that we could come to matching the pattern and frequency of human infant consumption of SFM. Based on the measured intake of SFM/kg/day and an average measured level of isoflavones in this brand of SFM of 25.5 mg aglucone/ l (Ministry of Agriculture, Food and Fisheries, 1998), intake of isoflavone per day in our study was probably in the range 1.6-3.5 mg/kg/day per marmoset over the 5-6 weeks of the study period. Based on actual ingestion of isoflavones, our study therefore averages~40-87% of the intake reported in 4 month human infants fed solely on SFM (Setchell et al., 1997) .
As we have not measured plasma isoflavone levels (such measurements are planned) it is not clear whether this difference in intake is matched by a difference in blood levels but, assuming similar rates of absorption and metabolism of isoflavones in the human and marmoset, our findings would suggest that similar and possibly more marked effects are likely to occur in human infants fed solely with SFM; effects are also likely in infants fed only partially on SFM. This conclusion takes no account of possible differences in responsiveness or sensitivity of marmoset versus human infants to isoflavenoid phytoestrogens, or other components of SFM, though it is generally accepted that marmosets may be relatively steroid-resistant when compared with humans (Lipsett et al., 1985) . A prolonged neonatal testosterone rise is a feature unique to male primates; no such event occurs in the female (Forest, 1990; Mann and Fraser, 1996; Andersson et al., 1998) . The role of this rise in the male primate remains unclear. Unlike in rodents it is not believed to play a critically important role in masculinization of sexual behaviour, as this is determined during fetal life rather than neonatally as in rodents (Meisel and Sachs, 1994) . Thus, studies in the rhesus monkey and marmoset in which the neonatal testosterone rise has been blocked by the administration of GnRH analogues have reported relatively minor (Eisler et al., 1993) or no (Lunn et al., 1994) effects respectively, in adulthood on sexual and their ratio (bottom) at the end of the feeding period (35-40 days of age) in co-twin marmosets fed with either standard (cow) formula milk (SMA) or soy formula milk (SFM). Each bar in the main panels represents one co-twin whilst overall mean levels for each treatment group are shown to the right. P-Values are based on co-twin comparison using the paired t-test after logarithmic transformation of the data.
behaviour, although neonatal castration of the tamarin was reported to have major effects on adult sexual behaviour that could not be rescued by androgen administration (Epple et al., 1990) . In both the rhesus and marmoset, suppression of the neonatal testosterone rise has no major effect in adulthood on sperm counts and fertility Lunn et al., 1994 Lunn et al., , 1997 Mann and Fraser, 1996) though there is a delay or prolongation of the pubertal rise in testosterone levels (Mann et al., 1989 Lunn et al., 1994; Mann and Fraser, 1996) and there are significant changes in testicular cell composition in adulthood, including an increase in Leydig cell numbers (Sharpe et al., 2000) ; perhaps because of these changes there may also be significant decrements in skeletal growth and in bone mineral density . Other effects of neonatal GnRH analogue treatment in male nonhuman primates have been reported, including subtle effects on the immune system and thymus weight (Mann and Fraser, 1996; Lunn et al., 1997) , and retardation of penis growth (Liu et al., 1991; Wallen et al., 1995; Brown et al., 1999) , though the latter may subsequently normalize during puberty (Wallen et al., 1995; Brown et al., 1999) . We did not measure penis length in all marmosets from the present study but, based on measurements in three sets of co-twins, there was no major difference in penis length at 40-45 days of age in SMA-and SFM-fed males (unpublished data). It seems likely that there are other roles for the neonatal testosterone rise, for example on development of the reproductive tract and prostate (Mann and Fraser, 1996; McKinnell et al., 2001) . We are unaware of any published studies that address this possibility but we have such studies in progress.
With regard to the human relevance of these studies in monkeys, the male human infant exhibits a pronounced neonatal testosterone rise between the ages of 1 and 5 months (Forest, 1990) . Although feeding with SFM may start at any time up to 5-6 months of age when intolerance of cow formula milk is suspected, in many infants SFM is the chosen breastmilk substitute and is fed within the first 4-5 months, and frequently from birth (Polack et al., 1999) . For human male infants fed with SFM within the first 3-4 months, significant attenuation of the neonatal testosterone rise is likely to occur, based on the present findings. Penile growth in the human male is reported to occur at a higher rate during the neonatal period than at any other phase of life (Danish et al., 1980) , as is the case in the rhesus monkey (Wallen et al., 1995) . Disorders of androgen production or action are associated with underdevelopment of the penis in the human male (Danish et al., 1980; George and Wilson, 1994) . Conversely, perinatal exposure to abnormally high androgen levels, as occurs in congenital adrenal hyperplasia, is associated with accelerated development of the penis , though the same authors have questioned whether the growth of the penis neonatally is under testosterone control . There are conflicting views on the bioavailability of testosterone neonatally in the human male as levels of sex hormonebinding globulin (SHBG), to which most testosterone will be bound, are also high at this age (Huhtaniemi et al., 1986; Forest, 1990) ; SHBG is also present in the plasma of neonatal marmosets (unpublished data). Isoflavones have been shown to stimulate SHBG production in vitro by (human) HepG2 liver cells (Mousavi and Adlercreutz, 1993) and to induce small increases in SHBG in vivo in adult men (Habito et al., 2000) , changes that would be expected to decrease bioavailability of testosterone. However, a number of studies have also shown that soy isoflavones can themselves bind to SHBG and compete with or displace testosterone, thus increasing bioavailable (ϭ free) testosterone (Martin et al., 1995; Dechaud et al., 1999) . The net effect of these various changes on testosterone bioavailability is difficult to predict without direct measurement in infants. Irrespective of the foregoing uncertainties, the conservation of the neonatal testosterone rise in all primate species studied (Mann and Fraser, 1996; Brown et al., 1999) suggests strongly that it must play some biological role(s). However, in view of uncertainty about its precise roles, it is difficult to predict whether potential effects of feeding human infants with SFM on the neonatal testosterone rise are likely to result in biologically important changes. Such changes, if they occur, may not necessarily be adverse.
In the absence of data for blood levels of LH, it is difficult to offer a conclusive explanation for the mechanism via which SFM feeding was able to suppress testosterone levels in the infant marmosets. A deficiency in Leydig cells is ruled out (see below) but a reduction in blood LH levels cannot be excluded. Though our studies of immunoexpression of LHβ (and FSHβ) in the pituitary gland produced no consistent evidence for suppression in SFM-fed co-twins (when compared with their brothers), this finding cannot be interpreted unequivocally as reflecting no change in LH (FSH) secretion. In this regard, s.c. administration of genistein at 2.5 mg/kg/day to adult mice has been shown to reduce both blood testosterone levels and pituitary LH content (Strauss et al., 1998) , and other studies in adult rats, using a much higher dose of genistein (100 mg/kg/day), have shown almost complete suppression of testosterone levels (Schleicher et al., 1999) . A recent study in which adult rats were fed for 5 weeks with a diet containing levels of soy phytoestrogens equivalent to those in a traditional Asian diet showed a 50% reduction in mean testosterone levels with no change in LH levels (Weber et al., 2001) ; however, other studies using relatively low levels of isoflavone exposure via the diet had no effect on testosterone levels (Weber et al., 1999) . Our present studies also suggest that, neonatally, testosterone levels in the marmoset are sensitive to isoflavones in soy or to some other constituent of the SFM. With regard to the mechanism of SFM-induced testosterone suppression, it is relevant that administration of potent estrogens to adult rats also suppresses testosterone production, and this is thought to occur at least partly via suppression of activity of the key steroidogenic enzyme 17α-hydroxylase/C 17-20 lyase in Leydig cells (Cigorraga et al., 1980) . Suppression of this enzyme in neonatal marmosets exposed to the phytoestrogens in SFM was therefore considered but, based on intensity of immunoexpression, we failed to demonstrate a consistent reduction. In considering such possibilities it should be kept in mind that fetal Leydig cells (to which neonatal Leydig cells may be more akin) can respond differently to hormonal stimuli than do the adult generation of Leydig cells (Huhtaniemi, 1994) , although the available evidence suggests that suppression of 17α-hydroxylase/C 17-20 lyase in fetal Leydig cells still occurs in the rat after oestrogen administration to the pregnant mother (Majdic et al., 1996) . Even if this is the mechanism behind the suppression of testosterone levels in SFM-fed infant marmosets, it would fail to explain the increase in Leydig cell numbers (see below) which, in the adult rat, are negatively regulated by potent estrogens (Abney, 1999 ). The present finding that feeding infant marmosets with SFM resulted in a consistent increase in Leydig cell numbers was unexpected, and even more so when considering that testosterone levels in the same animals were suppressed. We are unable as yet to offer any mechanistic explanation for this finding but similar Leydig cell hyperplasia associated with gross suppression of testosterone levels, and under-masculinization of the fetus, has been reported for the fetal rat testis after exposure in utero to a phthalate ester (Parks et al., 2000) . It is unclear what the longer-term consequences of this fetal Leydig cell hyperplasia might be. In marmosets in which the neonatal testosterone rise is blocked by GnRH antagonist treatment, Leydig cells atrophy, although their numbers prob-ably do not decrease greatly (Prince et al., 1998) . These animals show a delayed rise in blood testosterone levels at puberty (Lunn et al., 1994) but by adulthood testosterone levels have normalized (Lunn et al., 1994; Sharpe et al., 2000) and there is an increase in Leydig cell volume per testis (Sharpe et al., 2000) . It therefore remains debatable whether an increase in Leydig cell numbers neonatally will advance the onset of the pubertal rise in testosterone levels or alter Leydig cell numbers or function in adulthood. Hopefully, our ongoing studies of SFM-fed infant marmosets as they progress through puberty into adulthood will resolve this uncertainty.
The present findings do not show any effect of feeding with SFM on Sertoli and germ cell numbers, so, based on our present understanding of Sertoli cell development in the marmoset and its similarity to the human (Sharpe et al., 2000) , these findings are reassuring in suggesting that infant feeding with SFM is unlikely to affect sperm counts in adulthood. Nevertheless, it would seem worthwhile to consider comparative studies of sperm counts in adult men who were fed with SFM in infancy in order to confirm that no adverse effects have occurred.
Although our findings demonstrate significant effects of feeding SFM to infant marmosets, we are unable at present to fully interpret these findings or to predict whether the changes observed will lead to long-term consequences. Once our ongoing cohort of SFM-fed animals reach adulthood (in late 2002-2003) , some of this uncertainty should be resolved. Clearly, longitudinal prospective studies and retrospective studies in human infants fed with SFM will also be essential to such an evaluation. However, one obstacle to this evaluation is our current lack of understanding of the roles of the neonatal testosterone rise. It will therefore be important to gain better insight into this event in order that longer-term 'safety' evaluation can focus on target tissues that are normally influenced by the neonatal rise in testosterone levels. Our present plans are to focus on the reproductive tract, including the developing prostate, and the immune system. In the absence of the foregoing information, it is premature to make recommendations regarding the risk/benefits of feeding SFM to children. Nevertheless, the most cautious interpretation of our findings is that feeding human infant males with SFM in the first 3-5 months of life will exert effects on the neonatal testosterone rise and consequently on tissues/processes that are affected or regulated by this increase. Until we know what these tissues/processes are, it would seem prudent to avoid feeding infants with SFM whenever alternatives are possible.
